109 related articles for article (PubMed ID: 1826656)
1. Plasmodium falciparum: in vitro drug interaction between chloroquine and enantiomers of amlodipine.
Basco LK; Le Bras J
Exp Parasitol; 1991 Apr; 72(3):262-70. PubMed ID: 1826656
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo potentiation of chloroquine against malaria parasites by an enantiomer of amlodipine.
Deloron P; Basco LK; Dubois B; Gaudin C; Clavier F; Le Bras J; Verdier F
Antimicrob Agents Chemother; 1991 Jul; 35(7):1338-42. PubMed ID: 1834011
[TBL] [Abstract][Full Text] [Related]
3. Reversal of chloroquine resistance in falciparum malaria by some calcium channel inhibitors and optical isomers is independent of calcium channel blockade.
Ye Z; Van Dyke K
Drug Chem Toxicol; 1994; 17(2):149-62. PubMed ID: 8062642
[TBL] [Abstract][Full Text] [Related]
4. Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance.
Krogstad DJ; Gluzman IY; Kyle DE; Oduola AM; Martin SK; Milhous WK; Schlesinger PH
Science; 1987 Nov; 238(4831):1283-5. PubMed ID: 3317830
[TBL] [Abstract][Full Text] [Related]
5. Chloroquine-potentiating action of antihistaminics in Plasmodium falciparum in vitro.
Basco LK; Ringwald P; Le Bras J
Ann Trop Med Parasitol; 1991 Apr; 85(2):223-8. PubMed ID: 1686703
[TBL] [Abstract][Full Text] [Related]
6. Isradipine--a calcium channel blocker--does not potentiate chloroquine antiplasmodial activity against Plasmodium falciparum.
Randrianarivelojosia M; Jambou R
Parasite; 2005 Jun; 12(2):187-9. PubMed ID: 15991834
[TBL] [Abstract][Full Text] [Related]
7. Plasmodium falciparum: modulation by calcium antagonists of resistance to chloroquine, desethylchloroquine, quinine, and quinidine in vitro.
Kyle DE; Oduola AM; Martin SK; Milhous WK
Trans R Soc Trop Med Hyg; 1990; 84(4):474-8. PubMed ID: 2091331
[TBL] [Abstract][Full Text] [Related]
8. Reversal of chloroquine resistance in Plasmodium falciparum by verapamil.
Martin SK; Oduola AM; Milhous WK
Science; 1987 Feb; 235(4791):899-901. PubMed ID: 3544220
[TBL] [Abstract][Full Text] [Related]
9. Regulation of intracellular glutathione levels in erythrocytes infected with chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum.
Meierjohann S; Walter RD; Müller S
Biochem J; 2002 Dec; 368(Pt 3):761-8. PubMed ID: 12225291
[TBL] [Abstract][Full Text] [Related]
10. Inoculum effect with chloroquine and Plasmodium falciparum.
Gluzman IY; Schlesinger PH; Krogstad DJ
Antimicrob Agents Chemother; 1987 Jan; 31(1):32-6. PubMed ID: 3551825
[TBL] [Abstract][Full Text] [Related]
11. Synergy between two calcium channel blockers, verapamil and fantofarone (SR33557), in reversing chloroquine resistance in Plasmodium falciparum.
Adovelande J; Delèze J; Schrével J
Biochem Pharmacol; 1998 Feb; 55(4):433-40. PubMed ID: 9514077
[TBL] [Abstract][Full Text] [Related]
12. Uptake and efflux of chloroquine by chloroquine-resistant Plasmodium falciparum clones recently isolated in Africa.
Bayoumi RA; Babiker HA; Arnot DE
Acta Trop; 1994 Nov; 58(2):141-9. PubMed ID: 7887339
[TBL] [Abstract][Full Text] [Related]
13. In vitro evaluation of verapamil and other modulating agents in Brazilian chloroquine-resistant Plasmodium falciparum isolates.
Menezes CM; Kirchgatter K; Di Santi SM; Savalli C; Monteiro FG; Paula GA; Ferreira EI
Rev Soc Bras Med Trop; 2003; 36(1):5-9. PubMed ID: 12715057
[TBL] [Abstract][Full Text] [Related]
14. A novel pyrrolidonoalkaneamine (WR268954) that modulates chloroquine resistance of Plasmodium falciparum in vitro.
De D; Bhaduri AP; Milhous WK
Am J Trop Med Hyg; 1993 Jul; 49(1):113-20. PubMed ID: 8352383
[TBL] [Abstract][Full Text] [Related]
15. Hemozoin production by Plasmodium falciparum: variation with strain and exposure to chloroquine.
Orjih AU; Fitch CD
Biochim Biophys Acta; 1993 Jul; 1157(3):270-4. PubMed ID: 8323956
[TBL] [Abstract][Full Text] [Related]
16. Verapamil reversal of chloroquine resistance in the malaria parasite Plasmodium falciparum is specific for resistant parasites and independent of the weak base effect.
Martiney JA; Cerami A; Slater AF
J Biol Chem; 1995 Sep; 270(38):22393-8. PubMed ID: 7673225
[TBL] [Abstract][Full Text] [Related]
17. Selective antimalarial activity of tetrandrine against chloroquine resistant Plasmodium falciparum.
Ye ZG; Van Dyke K
Biochem Biophys Res Commun; 1989 Feb; 159(1):242-8. PubMed ID: 2647081
[TBL] [Abstract][Full Text] [Related]
18. Plasmodium chabaudi: association of reversal of chloroquine resistance with increased accumulation of chloroquine in resistant parasites.
Miki A; Tanabe K; Nakayama T; Kiryon C; Ohsawa K
Exp Parasitol; 1992 Mar; 74(2):134-42. PubMed ID: 1740175
[TBL] [Abstract][Full Text] [Related]
19. A verapamil-sensitive chloroquine-associated H+ leak from the digestive vacuole in chloroquine-resistant malaria parasites.
Lehane AM; Hayward R; Saliba KJ; Kirk K
J Cell Sci; 2008 May; 121(Pt 10):1624-32. PubMed ID: 18445688
[TBL] [Abstract][Full Text] [Related]
20. Alternative mutations at position 76 of the vacuolar transmembrane protein PfCRT are associated with chloroquine resistance and unique stereospecific quinine and quinidine responses in Plasmodium falciparum.
Cooper RA; Ferdig MT; Su XZ; Ursos LM; Mu J; Nomura T; Fujioka H; Fidock DA; Roepe PD; Wellems TE
Mol Pharmacol; 2002 Jan; 61(1):35-42. PubMed ID: 11752204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
